Details of the Drug
General Information of Drug (ID: DMS5HX0)
| Drug Name |
IVL745
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
F387KG9Ith; UNII-F387KG9ITH; F387KG9ITH; XRP 1745A; IVL 745; SCHEMBL6136116; DTXSID9043930; NOCAS_43930; IVL-745; 229627-58-1; beta-Alanine, N-((3-methoxy-4-((((2-methylphenyl)amino)carbonyl)amino)phenyl)acetyl)glycyl-N-((3,4-dimethoxyphenyl)methyl)-
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

